View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

Join NSF at 78th FIP World Congress of Pharmacy and Pharmaceutical Sciences, Glasgow

NSF will be exhibiting at the 2018 International Pharmaceutical Federation (FIP) World Congress in Glasgow, Scotland.

The theme of the congress is ‘Pharmacy: Transforming Outcomes!’.

Join NSF in Glasgow for a chat with the director of pharma-biotech Catherine Kay and QP administrator and UK office manager Stella Pearson-Smith at stand 6a in hall 4.

Learn more about NSF’s services, including consulting, auditing, regulatory support and training, as well as its Qualified Person training programme, which we have been running since 1990 in conjunction with the University of Strathclyde in Scotland.

Hosted in conjunction with the Royal Pharmaceutical Society, this unique FIP congress will bring together pharmacy practitioners and pharmaceutical scientists from around the world to consider ways of extending the role of pharmacists so that they play a full part in ensuring patients, and health systems, achieve full benefit from the medicines people take.

The one-size-fits-all approach is clearly failing many patients worldwide for the pharmacological treatment of disease. Pharmacists and pharmaceutical scientists are uniquely trained and qualified healthcare professionals capable of personalising therapy for improving patient outcomes.

NSF looks forward to seeing you next month in Glasgow. It will be offering a 20% discount on any of its training courses when you book at its stand during the event!

NSF Pharma Biotech's CEO Martin Lush recently had a meeting with a CEO to help solve his company’s pain points.
Making a case for good manufacturing practice (GMP) certification of an excipient manufacturer should be a straightforward exercise since the benefits appear so clear cut...
Risk management across a global supply chain has never been a stronger factor in assuring economic success than it is now.
The heart of the European Union (EU) regulation of in vitro diagnostic medical devices (IVDs) lies in allowing market access to IVDs that offer clinical...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology